Humana - HUM Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Hold
Consensus Price Target: $424.50
Forecasted Upside: 32.43%
Number of Analysts: 19
Breakdown:
0 Sell Ratings
10 Hold Ratings
9 Buy Ratings
0 Strong Buy Ratings

^$320.54 As of 05/3/2024 01:00 AM ET

▼ -0.44 (-0.14%)

1 month | 3 months | 12 months

Get New Humana Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for HUM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HUM

^$424.50

▲ +32.43% Upside Potential

This price target is based on 19 analysts offering 12 month price targets for Humana in the last 3 months. The average price target is $424.50, with a high forecast of $624.00 and a low forecast of $310.00. The average price target represents a 32.43% upside from the last price of $320.54.

Current Consensus is Hold

The current consensus among 19 polled investment analysts is to hold stock in Humana. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
9 buy ratings
10 hold ratings
0 sell ratings

Ratings as of

11/11/2022

0 strong buy ratings
9 buy ratings
10 hold ratings
0 sell ratings

Ratings as of

2/9/2023

0 strong buy ratings
9 buy ratings
10 hold ratings
0 sell ratings

Ratings as of

5/10/2023

0 strong buy ratings
9 buy ratings
10 hold ratings
0 sell ratings

Ratings as of

8/8/2023

0 strong buy ratings
9 buy ratings
10 hold ratings
0 sell ratings

Ratings as of

11/6/2023

0 strong buy ratings
9 buy ratings
10 hold ratings
0 sell ratings

Ratings as of

2/4/2024

0 strong buy ratings
9 buy ratings
10 hold ratings
0 sell ratings

Ratings as of

4/4/2024

0 strong buy ratings
9 buy ratings
10 hold ratings
0 sell ratings

Ratings as of

5/4/2024

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/25/2024	Royal Bank of Canada	Lower Target	Outperform ➝ Outperform	$415.00 ➝ $353.00	Low
4/25/2024	Cantor Fitzgerald	Lower Target	Neutral ➝ Neutral	$391.00 ➝ $360.00	Low
4/25/2024	UBS Group	Lower Target	Neutral ➝ Neutral	$334.00 ➝ $326.00	Low
4/25/2024	Oppenheimer	Lower Target	Outperform ➝ Outperform	$415.00 ➝ $370.00	Low
4/22/2024	Jefferies Financial Group	Lower Target	Buy ➝ Buy	$411.00 ➝ $381.00	Low
4/10/2024	Cantor Fitzgerald	Reiterated Rating	Neutral ➝ Neutral	$391.00	Low
4/8/2024	Wells Fargo & Company	Lower Target	Overweight ➝ Overweight	$413.00 ➝ $350.00	Low
4/4/2024	Cantor Fitzgerald	Reiterated Rating	Neutral ➝ Neutral	$391.00	Low
4/3/2024	The Goldman Sachs Group	Lower Target	Buy ➝ Buy	$450.00 ➝ $385.00	Low
4/2/2024	Barclays	Lower Target	Equal Weight ➝ Equal Weight	$356.00 ➝ $310.00	Low
4/2/2024	TD Cowen	Lower Target	Buy ➝ Buy	$427.00 ➝ $396.00	Low
4/2/2024	Bank of America	Reiterated Rating	Buy ➝ Neutral	$470.00 ➝ $342.00	Low
3/22/2024	Raymond James	Initiated Coverage	Market Perform		Low
3/13/2024	Argus	Downgrade	Buy ➝ Hold		Low
3/6/2024	Barclays	Initiated Coverage	Equal Weight	$356.00	Low
1/30/2024	Wells Fargo & Company	Lower Target	Overweight ➝ Overweight	$465.00 ➝ $413.00	Low
1/26/2024	Mizuho	Lower Target	Buy ➝ Buy	$550.00 ➝ $400.00	Low
1/26/2024	Stephens	Lower Target	Overweight ➝ Overweight	$550.00 ➝ $430.00	Low
1/26/2024	Cantor Fitzgerald	Downgrade	Overweight ➝ Neutral	$597.00 ➝ $391.00	Low
1/26/2024	Royal Bank of Canada	Lower Target	Outperform ➝ Outperform	$507.00 ➝ $415.00	Low
1/26/2024	UBS Group	Reiterated Rating	Buy ➝ Neutral	$530.00 ➝ $370.00	Low
1/26/2024	The Goldman Sachs Group	Lower Target	Buy ➝ Buy	$515.00 ➝ $450.00	Low
1/25/2024	Deutsche Bank Aktiengesellschaft	Downgrade	Buy ➝ Hold	$595.00 ➝ $360.00	Low
1/19/2024	Truist Financial	Reiterated Rating	Hold ➝ Hold	$550.00	Low
1/19/2024	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$597.00	Low
1/19/2024	The Goldman Sachs Group	Lower Target	Buy ➝ Buy	$595.00 ➝ $515.00	Low
1/19/2024	Royal Bank of Canada	Lower Target	Outperform ➝ Outperform	$599.00 ➝ $507.00	Low
1/17/2024	Oppenheimer	Reiterated Rating	Outperform ➝ Outperform	$630.00	Low
12/12/2023	Argus	Upgrade	Hold ➝ Buy	$550.00	Low
11/21/2023	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$597.00	Low
11/17/2023	JPMorgan Chase & Co.	Lower Target	Neutral ➝ Neutral	$593.00 ➝ $575.00	Low
11/2/2023	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$597.00	Low
11/2/2023	Stephens	Lower Target	Overweight ➝ Overweight	$575.00 ➝ $570.00	Low
11/2/2023	Royal Bank of Canada	Boost Target	Outperform ➝ Outperform	$594.00 ➝ $599.00	N/A
10/10/2023	Sanford C. Bernstein	Lower Target		$599.00 ➝ $579.00	Low
10/9/2023	Jefferies Financial Group	Boost Target	Buy ➝ Buy	$580.00 ➝ $586.00	Low
9/14/2023	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$597.00	Low
8/30/2023	Morgan Stanley	Lower Target	Overweight ➝ Overweight	$637.00 ➝ $624.00	Low
8/15/2023	TD Cowen	Lower Target	Outperform ➝ Outperform	$616.00 ➝ $613.00	Low
8/8/2023	Sanford C. Bernstein	Boost Target	Market Perform ➝ Market Perform	$568.00 ➝ $599.00	Low
8/7/2023	Deutsche Bank Aktiengesellschaft	Boost Target	Buy ➝ Buy	$468.00 ➝ $628.00	Low
8/3/2023	Stephens	Boost Target	Overweight ➝ Overweight	$555.00 ➝ $560.00	Low
8/3/2023	Royal Bank of Canada	Lower Target	Outperform ➝ Outperform	$637.00 ➝ $594.00	Low
8/3/2023	Truist Financial	Boost Target	Hold ➝ Hold	$530.00 ➝ $550.00	Low
7/14/2023	Morgan Stanley	Reiterated Rating	Overweight ➝ Overweight	$637.00	Low
7/13/2023	Wells Fargo & Company	Lower Target		$610.00 ➝ $541.00	Low
7/11/2023	Mizuho	Lower Target		$615.00 ➝ $550.00	Low
7/7/2023	JPMorgan Chase & Co.	Downgrade	Overweight ➝ Neutral	$576.00 ➝ $540.00	Low
6/23/2023	Argus	Downgrade	Buy ➝ Hold		Low
6/20/2023	Truist Financial	Lower Target		$590.00 ➝ $530.00	Low
6/19/2023	Barclays	Lower Target		$620.00 ➝ $585.00	Low
5/30/2023	JPMorgan Chase & Co.	Lower Target		$625.00 ➝ $576.00	Low
4/27/2023	Deutsche Bank Aktiengesellschaft	Boost Target		$562.00 ➝ $568.00	Low
4/27/2023	SVB Securities	Lower Target		$640.00 ➝ $600.00	Low
4/20/2023	Cantor Fitzgerald	Initiated Coverage	Overweight	$597.00	Low
4/13/2023	Truist Financial	Boost Target	Hold	$560.00 ➝ $590.00	Low
4/11/2023	Morgan Stanley	Boost Target	Overweight	$620.00 ➝ $637.00	Low
2/28/2023	Deutsche Bank Aktiengesellschaft	Lower Target	Buy	$575.00 ➝ $562.00	Low
2/7/2023	Truist Financial	Lower Target	Hold	$580.00 ➝ $560.00	Low
2/6/2023	Cowen	Lower Target	Outperform	$647.00 ➝ $581.00	Low
2/6/2023	Credit Suisse Group	Lower Target	Outperform	$635.00 ➝ $575.00	Low
2/3/2023	Stephens	Lower Target	Overweight	$625.00 ➝ $590.00	Low
2/2/2023	UBS Group	Lower Target	Buy	$645.00 ➝ $620.00	Low
1/6/2023	JPMorgan Chase & Co.	Lower Target	Overweight	$630.00 ➝ $625.00	Low
12/13/2022	The Goldman Sachs Group	Upgrade	Neutral ➝ Buy	$575.00 ➝ $652.00	Low
11/10/2022	Mizuho	Boost Target	Buy	$529.00 ➝ $615.00	Low
11/8/2022	Wells Fargo & Company	Boost Target		$558.00 ➝ $610.00	Low
11/7/2022	Cowen	Boost Target		$547.00 ➝ $647.00	Low
11/7/2022	Cowen	Boost Target		$547.00 ➝ $647.00	Low
11/3/2022	The Goldman Sachs Group	Boost Target	Neutral	$522.00 ➝ $575.00	Low
11/3/2022	SVB Leerink	Boost Target	Outperform	$540.00 ➝ $640.00	Low
11/3/2022	Truist Financial	Boost Target		$570.00 ➝ $650.00	Low
11/3/2022	Royal Bank of Canada	Boost Target	Outperform	$560.00 ➝ $637.00	Low
11/3/2022	Credit Suisse Group	Boost Target	Outperform	$548.00 ➝ $635.00	Low
10/31/2022	Morgan Stanley	Boost Target	Overweight	$549.00 ➝ $620.00	Low
10/26/2022	Deutsche Bank Aktiengesellschaft	Upgrade	Hold ➝ Buy	$514.00 ➝ $576.00	Low
9/20/2022	Royal Bank of Canada	Boost Target	Outperform	$541.00 ➝ $544.00	Low
9/20/2022	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight	$494.00 ➝ $549.00	Low
9/16/2022	Truist Financial	Boost Target	Hold	$550.00 ➝ $570.00	Low
9/16/2022	Oppenheimer	Boost Target	Outperform	$520.00 ➝ $550.00	Low
8/9/2022	Cowen	Boost Target		$547.00	Low
8/2/2022	Morgan Stanley	Boost Target	Equal Weight	$453.00 ➝ $494.00	Low
7/28/2022	SVB Leerink	Boost Target	Outperform	$535.00 ➝ $540.00	Low
7/28/2022	Deutsche Bank Aktiengesellschaft	Boost Target		$450.00 ➝ $514.00	Low
7/28/2022	Oppenheimer	Boost Target	Outperform	$510.00 ➝ $520.00	Low
7/19/2022	Credit Suisse Group	Set Target		$548.00	Low
7/14/2022	Truist Financial	Boost Target	Hold	$490.00 ➝ $550.00	Low
6/16/2022	Loop Capital	Initiated Coverage	Buy	$510.00	Medium
5/26/2022	Sanford C. Bernstein	Initiated Coverage	Market Perform	$480.00 ➝ $506.00	Medium
5/25/2022	Wells Fargo & Company	Boost Target	Overweight	$512.00 ➝ $514.00	Low
4/28/2022	Wells Fargo & Company	Boost Target		$491.00 ➝ $512.00	High
4/13/2022	UBS Group	Upgrade	Neutral ➝ Buy	$486.00 ➝ $520.00	Medium
4/7/2022	Truist Financial	Boost Target		$460.00 ➝ $490.00	High
3/9/2022	Morgan Stanley	Boost Target	Equal Weight	$410.00 ➝ $436.00	Low
2/3/2022	Deutsche Bank Aktiengesellschaft	Boost Target		$418.00 ➝ $435.00	Medium
2/3/2022	SVB Leerink	Lower Target	Outperform	$528.00 ➝ $525.00	Medium
1/11/2022	Sanford C. Bernstein	Lower Target		$470.00 ➝ $431.00	Low
1/7/2022	Mizuho	Reiterated Rating	Buy	$500.00	High
1/7/2022	UBS Group	Reiterated Rating	Hold	$486.00	High
1/7/2022	BMO Capital Markets	Lower Target		$490.00 ➝ $415.00	Low
1/7/2022	Wells Fargo & Company	Lower Target		$529.00 ➝ $452.00	Low
1/7/2022	Deutsche Bank Aktiengesellschaft	Lower Target	Hold ➝ Hold	$476.00 ➝ $418.00	Low
1/7/2022	Morgan Stanley	Lower Target	Equal Weight	$530.00 ➝ $410.00	High
1/7/2022	Barclays	Lower Target	Overweight	$540.00 ➝ $490.00	High
1/6/2022	Wells Fargo & Company	Upgrade	Equal Weight ➝ Overweight	$492.00 ➝ $529.00	High
1/5/2022	Truist Financial	Boost Target	Hold ➝ Hold	$500.00 ➝ $520.00	Low
12/16/2021	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$559.00 ➝ $530.00	Low
12/14/2021	The Goldman Sachs Group	Initiated Coverage	Neutral	$472.00	High
11/10/2021	Mizuho	Boost Target	Buy	$480.00 ➝ $500.00	Low
11/9/2021	Deutsche Bank Aktiengesellschaft	Boost Target	Hold	$427.00 ➝ $456.00	Low
11/9/2021	Citigroup	Boost Target	Buy	$510.00 ➝ $528.00	Low
11/4/2021	Bank of America	Boost Target	Buy	$505.00 ➝ $530.00	Low
11/4/2021	Morgan Stanley	Boost Target	Overweight	$513.00 ➝ $559.00	Low
11/4/2021	Oppenheimer	Boost Target	Outperform	$480.00 ➝ $510.00	Medium
11/4/2021	Credit Suisse Group	Boost Target	Outperform	$500.00 ➝ $513.00	Medium
11/4/2021	SVB Leerink	Boost Target	Outperform	$494.00 ➝ $528.00	Medium
11/4/2021	Royal Bank of Canada	Boost Target	Outperform	$479.00 ➝ $525.00	Medium
11/4/2021	Barclays	Boost Target	Overweight	$500.00 ➝ $540.00	Medium
9/27/2021	SVB Leerink	Initiated Coverage	Outperform	$494.00	Low
9/9/2021	Cowen	Initiated Coverage	Outperform	$479.00	High
9/9/2021	Barclays	Initiated Coverage	Overweight	$500.00	Low
8/31/2021	Morgan Stanley	Boost Target	Overweight	$500.00 ➝ $513.00	Low
7/9/2021	Seaport Res Ptn	Reiterated Rating	Neutral		Low
7/9/2021	JPMorgan Chase & Co.	Boost Target	Overweight	$440.00 ➝ $514.00	Low
5/24/2021	Wells Fargo & Company	Initiated Coverage	Equal Weight	$472.00	N/A
5/18/2021	Wells Fargo & Company	Initiated Coverage	Equal Weight	$472.00	Medium
4/29/2021	Citigroup	Boost Target		$496.00 ➝ $510.00	Low
4/29/2021	Oppenheimer	Boost Target	Outperform	$460.00 ➝ $480.00	Low
4/29/2021	Mizuho	Boost Target	Buy	$462.00 ➝ $480.00	Medium
1/6/2021	Argus	Boost Target	Buy	$430.00 ➝ $450.00	N/A
1/4/2021	Royal Bank of Canada	Upgrade	Sector Perform ➝ Outperform	$429.00 ➝ $479.00	N/A
11/30/2020	SVB Leerink	Lower Target	Sell ➝ Outperform	$505.00 ➝ $500.00	High
11/4/2020	Smith Barney Citigroup	Boost Target		$469.00 ➝ $496.00	Low
11/4/2020	Credit Suisse Group	Boost Target	Outperform	$423.00 ➝ $465.00	Low
11/4/2020	Oppenheimer	Boost Target	Outperform	$440.00 ➝ $460.00	Low
11/4/2020	Stephens	Boost Target	Overweight	$450.00 ➝ $490.00	Low
10/13/2020	Truist Financial	Boost Target		$455.00 ➝ $475.00	Low
10/1/2020	Sanford C. Bernstein	Initiated Coverage	Market Perform	$459.00	Medium
10/1/2020	Piper Sandler	Boost Target	Overweight	$473.00 ➝ $495.00	Low
9/10/2020	Deutsche Bank Aktiengesellschaft	Boost Target	Hold	$397.00 ➝ $431.00	High
8/18/2020	JPMorgan Chase & Co.	Boost Target	Overweight	$394.00 ➝ $452.00	Low
8/17/2020	Royal Bank of Canada	Boost Target	Sector Perform	$388.00 ➝ $420.00	Low
8/10/2020	Stephens	Boost Target	Overweight	$433.00 ➝ $450.00	Low
8/7/2020	Mizuho	Boost Target	Buy	$420.00 ➝ $462.00	High
8/6/2020	Credit Suisse Group	Reiterated Rating	Buy		Low
8/6/2020	Piper Sandler	Boost Target	Overweight	$442.00 ➝ $473.00	Medium
8/6/2020	Oppenheimer	Boost Target	Outperform	$425.00 ➝ $440.00	Low
8/6/2020	SVB Leerink	Boost Target	Outperform	$465.00 ➝ $496.00	Medium
7/1/2020	SVB Leerink	Initiated Coverage	Outperform	$465.00	Low
6/18/2020	Deutsche Bank Aktiengesellschaft	Lower Target	Hold	$421.00 ➝ $397.00	Low
6/17/2020	Cantor Fitzgerald	Boost Target		$405.00 ➝ $410.00	Medium
6/16/2020	Cowen	Reiterated Rating	Outperform ➝ Market Perform	$410.00	Medium
6/5/2020	The Goldman Sachs Group	Initiated Coverage	Buy	$510.00	Medium
5/21/2020	SunTrust Banks	Boost Target	Hold	$400.00 ➝ $440.00	Low
5/4/2020	Mizuho	Boost Target	Buy	$405.00 ➝ $420.00	Low
4/30/2020	CSFB	Boost Target	Outperform	$400.00 ➝ $423.00	Medium
4/30/2020	Credit Suisse Group	Boost Target	Outperform	$400.00 ➝ $423.00	High
4/30/2020	Citigroup	Boost Target	Buy	$424.00 ➝ $435.00	Medium
4/30/2020	Morgan Stanley	Boost Target	Overweight	$375.00 ➝ $500.00	Medium
4/30/2020	Oppenheimer	Boost Target	Outperform	$400.00 ➝ $425.00	Medium
4/13/2020	Morgan Stanley	Boost Target	Overweight	$343.00 ➝ $375.00	Medium
3/29/2020	Barclays	Reiterated Rating	Buy		High
3/27/2020	Morgan Stanley	Lower Target	Overweight	$460.00 ➝ $343.00	Medium
2/19/2020	Royal Bank of Canada	Reiterated Rating	Hold	$370.00	Low
2/18/2020	Deutsche Bank Aktiengesellschaft	Boost Target	Hold	$363.00 ➝ $433.00	Medium
2/14/2020	Mizuho	Reiterated Rating	Buy	$405.00	N/A
2/6/2020	Morgan Stanley	Boost Target	Overweight	$457.00 ➝ $460.00	Low
2/6/2020	Deutsche Bank Aktiengesellschaft	Boost Target	Buy	$319.00 ➝ $363.00	Medium
2/6/2020	Mizuho	Boost Target	Buy	$400.00 ➝ $405.00	Medium
2/5/2020	Cantor Fitzgerald	Boost Target	Overweight	$345.00 ➝ $400.00	Low
1/27/2020	The Goldman Sachs Group	Reiterated Rating	Buy	$425.00	Medium
1/23/2020	UBS Group	Boost Target	Neutral	$321.00 ➝ $406.00	Low
1/8/2020	Credit Suisse Group	Boost Target	Outperform	$378.00 ➝ $400.00	High
1/3/2020	JPMorgan Chase & Co.	Boost Target	Overweight	$437.00 ➝ $448.00	Medium
1/3/2020	The Goldman Sachs Group	Reiterated Rating	Buy ➝ Buy	$425.00 ➝ $425.00	Medium
12/20/2019	JPMorgan Chase & Co.	Boost Target	Overweight	$322.00 ➝ $437.00	Low
12/17/2019	SunTrust Banks	Reiterated Rating	Hold	$370.00	Low
12/11/2019	Wells Fargo & Company	Reiterated Rating	Overweight	$338.00 ➝ $400.00	Low
12/6/2019	Barclays	Boost Target	Overweight	$327.00 ➝ $358.00	Low
11/20/2019	Argus	Boost Target	Buy	$370.00	Low
11/18/2019	Morgan Stanley	Reiterated Rating	Buy	$337.00 ➝ $360.00	Low
11/15/2019	SunTrust Banks	Boost Target	Positive ➝ Hold	$350.00	High
11/7/2019	SunTrust Banks	Boost Target	Hold	$335.00	High
10/17/2019	Mizuho	Initiated Coverage	Buy	$316.00	High
9/30/2019	BMO Capital Markets	Downgrade	Outperform ➝ Market Perform	$345.00 ➝ $290.00	Low
9/26/2019	Morgan Stanley	Lower Target	Overweight	$342.00 ➝ $337.00	High
9/12/2019	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Hold	$300.00	High
8/23/2019	Morgan Stanley	Boost Target	Overweight	$315.00 ➝ $342.00	Medium
8/12/2019	Cantor Fitzgerald	Upgrade	Neutral ➝ Overweight	$300.00 ➝ $345.00	Medium
8/1/2019	JPMorgan Chase & Co.	Boost Target	Overweight	$288.00 ➝ $322.00	Low
8/1/2019	Piper Sandler Companies	Boost Target	Overweight	$315.00 ➝ $341.00	Low
8/1/2019	UBS Group	Boost Target	Neutral	$266.00 ➝ $317.00	Low
8/1/2019	SunTrust Banks	Boost Target	Hold	$340.00	Low
7/12/2019	Morgan Stanley	Lower Target	Overweight	$331.00 ➝ $315.00	High

(Data available from 5/4/2019 forward)

News Sentiment Rating

0.57 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

37 very positive mentions
22 positive mentions
4 negative mentions
0 very negative mentions

Mentions as of

10/7/2023

23 very positive mentions
49 positive mentions
10 negative mentions
1 very negative mentions

Mentions as of

11/6/2023

36 very positive mentions
27 positive mentions
3 negative mentions
2 very negative mentions

Mentions as of

12/6/2023

33 very positive mentions
20 positive mentions
6 negative mentions
4 very negative mentions

Mentions as of

1/5/2024

38 very positive mentions
74 positive mentions
19 negative mentions
11 very negative mentions

Mentions as of

2/4/2024

30 very positive mentions
36 positive mentions
1 negative mentions
2 very negative mentions

Mentions as of

3/5/2024

31 very positive mentions
36 positive mentions
17 negative mentions
0 very negative mentions

Mentions as of

4/4/2024

38 very positive mentions
61 positive mentions
15 negative mentions
0 very negative mentions

Mentions as of

5/4/2024

Current Sentiment

Recent Stories by Sentiment

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Today's Range

Now: $320.54

$316.60

$321.04

50 Day Range

MA: $324.12

$302.09

$351.58

52 Week Range

Now: $320.54

$298.61

$541.21

Volume

1,802,675 shs

Average Volume

1,607,966 shs

Market Capitalization

$38.63 billion

P/E Ratio

19.96

Dividend Yield

1.13%

Beta

0.49

Frequently Asked Questions

What sell-side analysts currently cover shares of Humana?: The following sell-side analysts have issued reports on Humana in the last twelve months: Argus, Bank of America Co., Barclays PLC, Cantor Fitzgerald, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., JPMorgan Chase & Co., Mizuho, Morgan Stanley, Oppenheimer Holdings Inc., Raymond James, Royal Bank of Canada, Sanford C. Bernstein, Stephens, StockNews.com, TD Cowen, The Goldman Sachs Group, Inc., TheStreet, Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for HUM.
What is the current price target for Humana?: 18 Wall Street analysts have set twelve-month price targets for Humana in the last year. Their average twelve-month price target is $424.50, suggesting a possible upside of 32.4%. Morgan Stanley has the highest price target set, predicting HUM will reach $624.00 in the next twelve months. Barclays PLC has the lowest price target set, forecasting a price of $310.00 for Humana in the next year.
View the latest price targets for HUM.
What is the current consensus analyst rating for Humana?: Humana currently has 10 hold ratings and 9 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in HUM, but not buy more shares or sell existing shares.
View the latest ratings for HUM.
What other companies compete with Humana?: Other companies that are similar to Humana include GE HealthCare Technologies, Alcon, Haleon, Centene and IDEXX Laboratories. Learn More about companies similar to Humana.
How do I contact Humana's investor relations team?: Humana's physical mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider's listed phone number is (502) 580-1000 and its investor relations email address is [email protected]. The official website for Humana is www.humana.com. Learn More about contacing Humana investor relations.

Humana - HUM Stock Price Target and Predictions

Analyst Price Target for HUM

Current Consensus is Hold

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.57 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Humana?

What is the current price target for Humana?

What is the current consensus analyst rating for Humana?

What other companies compete with Humana?

How do I contact Humana's investor relations team?